Shanghai Pharmaceuticals Holding Co., Ltd (2607.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
| Market Cap | 37.91B |
| Enterprise Value | 54.66B |
| P/E Ratio | 11.66 |
| PEG Ratio | -1.36 |
| Price/Sales Ratio | 0.16 |
| Price/Book Ratio | 0.76 |
| Enterprise/Revenue | 0.25 |
| Enterprise/EBITDA | 6.13 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.02 |
| Operating Margin | 0.03 |
| Return On Assets | 0.02 |
| Return On Equity | 0.07 |
| Revenue | 283.58B |
| Revenue/Share | 78.6 |
| Gross Profit | 30.42B |
| EBITDA | 14.37B |
| Net Income | 5.72B |
| Diluted EPS | 1.54 |
| Total Cash | 42.23B |
| Total Cash/Share | 11.39 |
| Total Debt | 59.09B |
| Total Debt/Equity | 0.75 |
| Current Ratio | 1.35 |
| Book Value Per Share | 25.33 |
| 52-Week Change | -9.52 |
| 52-Week High | 12.39 |
| 52-Week Low | 10.7 |
| Moving Average 50 Days | 11.11 |
| Moving Average 200 Days | 11.59 |
| Average Volume | 1.76M |
| Shares Outstanding | 5.8B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.57 |
| Trailing Annual Dividend Yield | 3.52 |
| Payout Ratio | 0.66 |
| Last Split Factor | N/A |
| Last Split Date | N/A |